{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:26:25Z","timestamp":1773044785620,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T00:00:00Z","timestamp":1125014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold>Before the mid\u20101980s, haemophilia often was unknowingly treated with contaminated plasma products, resulting in high rates of human immunodeficiency virus (HIV\u20101), hepatitis C virus (HCV) and hepatitis B virus (HBV) infections. To estimate the impact of these infections, a new cohort was established. All HCV\u2010seropositive patients, age 13\u201388\u2003years, at 52 comprehensive haemophilia treatment centres were eligible. Cross\u2010sectional data collected during April 2001 to January 2004 (median June 2002) were analysed. Plasma HIV\u20101 and HCV RNA were quantified by polymerase chain reaction. Highly active antiretroviral therapy (HAART) was defined as use of at least three recommended medications. Among 2069 participants, 620 (30%) had HIV\u20101. Of 1955 with known HBV status, 814 (42%) had resolved HBV and 90 (4.6%) were HBV carriers. Although 80% of the HIV\u20101\u2010positive participants had \u2265200 CD4<jats:sup>+<\/jats:sup>cells\u2003<jats:italic>\u03bc<\/jats:italic>L<jats:sup>\u22121<\/jats:sup>, only 59% were on HAART. HIV\u20101 RNA was undetectable in 23% of those not taking antiretroviral medications. Most (72%) participants had received no anti\u2010HCV therapy. HCV RNA was detected less frequently (59%) among participants treated with standard interferon plus ribavirin (<jats:italic>P<\/jats:italic>\u2003=\u20030.0001) and more frequently among HIV\u20101\u2010positive than HIV\u20101\u2010negative participants (85% vs. 70%,<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). HIV\u20101\u2010positive participants were more likely to have pancytopenia and subclinical hepatic abnormalities, as well as persistent jaundice, hepatomegaly, splenomegaly and ascites. HAART recipients did not differ from HIV\u2010negative participants in the prevalence of ascites. The clinical abnormalities were more prevalent with older age but were not confounded by HBV status or self\u2010reported alcohol consumption. Eleven participants presented with or previously had hepatocellular carcinoma or non\u2010Hodgkin lymphoma. Although prospective analysis is needed, our data reveal the scale of hepatic and haematological disease that is likely to manifest in the adult haemophilic population during the coming years unless most of them are successfully treated for HIV\u20101, HCV or both.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2005.01138.x","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T09:32:38Z","timestamp":1125048758000},"page":"516-528","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001\u20132003"],"prefix":"10.1111","volume":"11","author":[{"given":"J. J.","family":"Goedert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Second Multicenter Hemophilia Cohort Study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,26]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"602","article-title":"Natural history of hepatitis C virus infection in multitransfused haemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study","volume":"6","author":"Eyster ME","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.1.254.254"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.2.412.412"},{"issue":"1","key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/jhep.2002.36806","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff LB.","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15109-4"},{"key":"e_1_2_7_7_2","first-page":"1584","article-title":"End\u2010stage liver disease in persons with hemophilia and transfusion\u2010associated infections","volume":"100","author":"Goedert JJ","year":"2002","journal-title":"Blood"},{"key":"e_1_2_7_8_2","first-page":"1095","article-title":"Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV. Multicenter Hemophilia Cohort Study","volume":"7","author":"Ehmann WC","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200402200-00020"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/378124a0"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05413-5"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1998.14.183"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.231140698"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200312050-00007"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907013410104"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26511"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20127"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280330"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198910263211701"},{"key":"e_1_2_7_20_2","first-page":"279","article-title":"HIV\u20101 infection incidence among persons with hemophilia in the United States and western Europe, 1978\u20131990. Multicenter Hemophilia Cohort Study","volume":"7","author":"Kroner BL","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.276.2.105"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200207050-00009"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00801.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04258-6"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2005.01138.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2005.01138.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T20:39:32Z","timestamp":1735936772000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2005.01138.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,26]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1365-2516.2005.01138.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2005.01138.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,26]]}}}